Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (181)
  2. Journal Article (123)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (3)
  7. Book Section (1)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (339)
  2. Department of Medicine (339)
  3. Hematologic Malignancies, Division of (339)
  4. Lymphoma (339)
  5. Population Sciences Research Program (220)
  6. Survivorship Research (141)

More Groups

People
  1. Steven Horwitz (220)
  2. Andrew Zelenetz (119)
  3. Paul Hamlin (107)
  4. Ariela Noy (106)
  5. David Straus (96)
  6. Matthew Matasar (95)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (136)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (21)
  4. Blood Advances (15)
  5. Journal of the American Academy of Dermatology (13)
  6. Leukemia and Lymphoma (13)

More Publications

Publishers
  1. American Society of Hematology (154)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (24)
  4. Elsevier Inc. (21)
  5. Taylor & Francis Group (14)
  6. Mosby Elsevier (13)

More Publishers

Results (339)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schöder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
    Journal Article

    Driessen, J.; Zwezerijnen, G. J. C.; Schöder, H.; Kersten, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Eertink, J. J.; Heymans, M. W.; Boellaard, R.; Zijlstra, J. M.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant (ASCT)
    Meeting Abstract

    Foley, N.; Russler-Germain, D.; Watkins, M.; Jacobsen, E.; Moskowitz, A.; Cashen, A.; Fehniger, T.; Kahl, B.; Bartlett, N.; Ghobadi, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: A 3-year follow-up
    Journal Article

    Zinzani, P. L.; Santoro, A.; Gritti, G.; Brice, P.; Barr, P. M.; Kuruvilla, J.; Cunningham, D.; Kline, J.; Johnson, N. A.; Mehta-Shah, N.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant
    Meeting Abstract

    Foley, N. C.; Russler-Germain, D.; Watkins, M.; Jacobsen, E. D.; Moskowitz, A. J.; Cashen, A. F.; Fehniger, T. A.; Kahl, B. S.; Ghobadi, A.; Reagan, B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
    Research Letter

    Santoro, A.; Moskowitz, A. J.; Ferrari, S.; Carlo-Stella, C.; Lisano, J.; Francis, S.; Wen, R. C.; Akyol, A.; Savage, K. J.
    Blood (2023)

    Fulltext@MSK | Save
  • Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T-cell lymphoma
    Journal Article

    Stuver, R.; Horwitz, S. M.; Advani, R. H.; Vose, J. M.; Lee, H. J.; Mehta-Shah, N.; Zain, J. M.; Haverkos, B.; Lechowicz, M. J.; Moskowitz, A. J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save